Application of the Latest Data in CLL/SLL: Guidance for Current and Future Treatment Strategies

Expert faculty review current paradigms and emerging data in treating chronic lymphocytic leukemia with a downloadable slideset from a satellite symposium and an expert commentary.

Share

Program Content

Activities

Treating R/R CLL
Considerations in Selecting Therapy for Previously Treated CLL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2022

Expires: December 08, 2023

View Activity
Frontline Therapy for CLL
Optimal Selection of Therapy for Treatment-Naive CLL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2022

Expires: December 08, 2023

View Activity
1D10D077-8F4E-46DD-A6C3-AAE5A6725B22Future Directions in CLL
Near Future Directions: Promising Strategies Under Investigation
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2022

Expires: December 08, 2023

View Activity

Activities

FAQ: Treating CLL
Experts Address HCP Questions on Contemporary Treatment for CLL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: January 30, 2023

Expires: January 29, 2024

View Activity

Faculty

cover img faculity

Brian Hill, MD, PhD

Director, Lymphoid Malignancies Program
Staff Physician, Department of Hematology and Medical Oncology
Taussig Cancer Institute
Cleveland Clinic
Cleveland, Ohio

cover img faculity

Deborah Stephens, DO

Associate Professor
Director of the CLL Program
Lineberger Comprehensive Cancer Center
University of North Carolina
Chapel Hill, North Carolina

cover img faculity

Jennifer Woyach, MD

D Warren Brown Professor of Leukemia Research
Section Head, CLL and Hairy Cell Leukemia
Associate Division Director for Clinical Research
Division of Hematology
Co-Leader Leukemia Research Program
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio

Provided by

ProCE Banner

Supporters

This CE activity is supported through an educational grant from

AstraZeneca

BeiGene

Lilly

Pharmacyclics LLC an AbbVie Company and Janssen Biotech Inc